Background. The optimal timing of cardiac operations in patients with infective endocarditis continues to be debated. This observational study analyzed the profile and outcome of patients with active infective endocarditis undergoing operations.
tified at admission, patients with native valve IE received antimicrobial therapy with flucloxacillin, ampicillin, and gentamicin, and patients with prosthetic valve IE (PVE) received antimicrobial therapy with vancomycin, gentamicin, and rifampicin. The Ethics Committee approved this study and waived the need for individual patient consent.
We excluded 2 patients with postponed cardiac operation due to cerebral bleeding and 3 patients with perioperatively detected IE. One patient who initially decided to refuse operation was excluded. The study excluded 26 patients who were referred to our center more than 7 days after initiation of adequate antibiotic therapy.
Data Collection
All data were prospectively collected in a database following a predefined protocol and independently reviewed by 3 experts [7] .
Cardiac Operation
Cardiac surgical interventions were performed according to predefined criteria [17] . Indications included severe valvular regurgitation with and without heart failure, abscess or perivalvular extension, failure of conservative medical treatment, and large vegetations exceeding 10 mm with high risk of embolization or (recurrent) embolization during antibiotic treatment.
Complications before and after surgical intervention and IE-related outcome up to 6 months follow-up were registered.
Definitions
Nosocomial IE was defined as IE occurring more than 72 hours after admission to the hospital or IE acquired in association with a significant invasive procedure performed during a recent hospitalization within 8 weeks before this hospitalization [2] .
Prosthetic valve endocarditis was classified as early PVE within 12 months after cardiac operation and late PVE after 12 months [11] .
Early cardiac operation was defined as surgical intervention within the first 7 days after diagnosis of IE and late cardiac operation as a procedure more than 7 days after diagnosis of IE up to immediately after completion of antibiotic treatment. The definition of "early" operation in most published studies was "valve replacement during the course of antimicrobial therapy." However, the early operation groups consisted of patients who were operated on within the first week of antimicrobial therapy up to the end of antibiotic therapy. The clinical profile of patients requiring cardiac operation within the first week of antimicrobial therapy might have differed from patients in whom intervention was performed in the last week before the end of antimicrobial therapy. Therefore, we aimed to divide this heterogenous group and decided to choose a cutoff of 7 days. If IE is associated with destructive and aggressive microorganisms, complications occur mainly early during the course of IE compared with low-virulent pathogens. 
Statistical Analysis

Results
Clinical Characteristics
The study included 95 IE patients, with a median age of 65 years (IQR, 54 to 73 years) and a male/female ratio of nearly 3/2. Of the 95 patients, 59 were referred to our hospital. Prosthetic valves were involved in 23 patients, of whom 11 underwent early operation and 12 late procedures. Nosocomial IE was present in 18 patients. The most frequent comorbid conditions were chronic obstructive pulmonary disease (COPD) in 11 patients and diabetes mellitus in 8 patients.
Staphylococci predominated and were the causative microorganisms in 35 patients. Methicillin-resistant Staphylococcus aureus (MRSA) was present in 4 patients. Streptococci were reported in 23 patients, followed by 
Surgical Characteristics
Operations were done in 36 patients because of severe regurgitation with heart failure, in 26 because of severe regurgitation without heart failure, in 13 
Complications
One or more major preoperative complication, including congestive heart failure, septic shock, or cardiogenic shock, was present in 40 patients; and one or more major postoperative complication, including congestive heart failure, septic shock, cardiogenic shock, or surgical reintervention, was observed in 23 patients. An abscess was present in 36 patients. Tables 1 and 2 summarize preoperatively and postoperatively diagnosed complications, respectively. Some complications were significantly associated with the causative pathogen. These data are presented in Table 3 . In particular, the rate of embolism was highest in staphylococcal IE (p ϭ 0.007). Abscess formation was also significantly associated with staphylococcal IE (p Ͻ 0.001), as was an association with septic shock (p ϭ 0.001). Congestive heart failure was most frequently present in the group of other microorganisms (p ϭ 0.004).
Outcome
The 6-month mortality rate was 15% (14 of 95). Table 4 presents mortality rates according to clinical characteristics. Mortality was significantly higher in IE caused by staphylococci than from the other pathogens (p ϭ 0.02). No patients with culture-negative IE died. The mortality rate did not differ significantly between the 8 of 59 patients (14%) who were referred to this hospital and the 6 of 36 patients (17%) who were immediately admitted to this hospital (p ϭ 0.7). There was no significant difference in mortality rate between the indications for cardiac operation (p ϭ 0.2); notably, no patients with severe regurgitation without heart failure died. Both patients who required a balloon pump died. A significant association was found between death and the aortic crossclamp time (p ϭ 0.049) and a nearly significant association with the cardiopulmonary bypass time (p ϭ 0.051).
When the factor timing of cardiac operation was studied as a continuous variable, there was a nearly significant association with death (p ϭ 0.09). When the timing of cardiac surgery was analyzed as a categoric variable with a cutoff of 7 days between early and late surgery, again a nearly significant association with death was found (p ϭ 0.07). The highest mortality rate was 21% and was observed in the patients (12 of 58) who had early operations vs 5% in the late group (2 of 37; Fig 1) . The mortality rate was 19% (3 of 16) in the true emergencies (Յ 24 hours) and 21% (9 of 42) in the remaining early patients. No patients died during the operation.
Variables that were analyzed for studying predictors of 6-month mortality included age, sex, PVE, nosocomial origin, comorbid conditions (diabetes mellitus, chronic obstructive pulmonary disease, cancer and immunosuppression), the causative microorganism, the timing of cardiac operation, and the complications, including cardiogenic shock, septic shock, embolism, heart failure, the presence of an abscess, severe regurgitation (Ն 3/4), and prosthetic valve dehiscence. In univariable analysis, factors associated with 6-month mortality in surgically treated patients were staphylococci (p ϭ 0.006) and septic shock (p Ͻ 0.001, Table 5 ). Multivariable logistic regression revealed that septic shock (odds ratio, 11.9; 95% confidence interval, 2.4 to 59.1; p ϭ 0.002) was independently associated with 6-month mortality. All patients who experienced preoperative septic shock belonged to the early operation group, of whom 4 of 7 (57%) died. 
Comment
The principal dilemma is whether to operate early to limit the risk of emboli and of severe cardiac insufficiency, or to delay surgical intervention until resolution of the infection to reduce the risk of operation and of relapse of IE. Previous studies compared early valve replacement vs medical treatment. The definition of "early" operation varied between the studies from "valve replacement during the course of antimicrobial therapy" to "surgery during the initial hospitalization for IE" [5, 10, 13]. Moreover, the early operation group consisted of patients who were operated on within the first week of antimicrobial therapy up to the end of antibiotic therapy. The clinical profile of patients requiring cardiac operation within the first week of antimicrobial therapy probably differed from patients who underwent operations in the last week before the end of antimicrobial therapy. Revilla and colleagues [15] found no significant difference in mortality between urgently (before antibiotic treatment has ended) and electively (at completion of antibiotic treatment) operated on patients. They stated, however, that patients with IE who needed an operation before antibiotic treatment had ended had a poor clinical course.
The present study aimed to investigate the clinical profile and predictors of outcome of patients requiring cardiac operation and studied the impact of timing of cardiac surgical intervention on 6-month mortality. The study included 95 surgically treated IE patients, and their overall 6-month mortality rate was 15%. According to our results, diabetes mellitus did not influence prognosis. In contrast, Chu and colleagues [19] identified diabetes mellitus as an independent risk factor for death; however, their data were from a study that included medically and surgically treated patients. Despite a higher mortality rate of prosthetic than of native valve endocarditis, the presence of a prosthetic valve did not appear to be a predictor of death. Staphylococci were the predominant causative microorganisms and were associated with the highest mortality rate. Only in univariate analysis was there a significant association between staphylococci and death. However, staphylococcal IE was associated with embolism, abscess formation, and septic shock, concluding that staphylococci are indirectly predictors of an unfavorable clinical course and outcome.
When we evaluated the impact of timing of cardiac surgery on mortality, we found a nearly significant association by univariate analysis; however, this difference might have been significant if more patients had been involved in this study. The prognosis in patients who were operated on more than 7 days after diagnosis of IE was relatively favorable because only 5% died. In contrast, in patients in whom the intervention was performed within 7 days of diagnosis of IE, the mortality rate was more than a fourfold higher. Likely, this difference was not due to the timing of the cardiac operation itself but to the severity of the disease.
Congestive heart failure, the most common indication for operation in this study, was not significantly associated with death. As well, Revilla and colleagues [15] found that congestive heart failure, also the main cause of urgent operation, was not significantly associated with death in patients with an early procedure. Their explanation for this finding was that heart failure is caused by a localized problem at the valve that can be treated successfully by surgical intervention.
In studying predictors of death in surgically treated patients, we found that septic shock was an independent predictive factor of 6-month mortality. In contrast to congestive heart failure, septic shock represents uncontrolled systemic and disseminated infection. This unfavorable clinical status cannot be resolved by a local cardiac intervention and may explain why septic shock was associated with a high mortality rate. Patients experiencing preoperative septic shock had a very high mortality rate despite undergoing early cardiac operation.
In this series, no patients with the indication for operation of "severe regurgitation without heart failure" died. These results may suggest that early operation in patients with severe regurgitation without heart failure may be beneficial: outcome results were similar to the late surgically treated group, and the length of hospitalization may be shorter than in patients with an elective operation later during or at the end of antimicrobial therapy. Moreover, new heart failure developed during antibiotic therapy in more than one-fifth of patients who underwent a late operation, which might have been avoided by an early cardiac intervention.
Limitations of this study are that it lacked a randomized controlled treatment strategy. This study reported findings of a single tertiary-care referral center, resulting in limitations to the generalization of the results. Owing to the relative low number of patients included in this study and the low mortality rate, some risk factors might not have reached statistical significance.
In conclusion, septic shock predicted 6-month mortality, and even by performing early cardiac intervention in patients with a preoperative septic shock, the mortality rate remained considerable. The prognosis in patients who were operated on late was favorable compared with those who had an early operation, but this difference was probably not due to the timing of the intervention but to the severity of IE.
Only in patients without life-threatening complications, such as severe regurgitation without heart failure, is the discussion about early or late operation meaningful. Our results show that the outcome did not differ between early and late operation in patients with severe regurgitation without heart failure. Therefore in these patients, early operation may offer benefit in length of hospitalization and prevention of development of new heart failure. However, future and larger studies are needed to convincingly pass a verdict in this topic.
